Literature DB >> 30675470

The Incidence of Binocular Visual Impairment and Blindness in Children with Bilateral Retinoblastoma.

Andrew W Stacey1,2,3, Bronagh Clarke1,2, Christos Moraitis4, Ido Didi Fabian1,2, Vicki Smith4, Mandeep S Sagoo1,2,5, M Ashwin Reddy1,2.   

Abstract

PURPOSE: The study aimed to assess the incidence of and risk factors leading to visual impairment and legal blindness in children with retinoblastoma. PROCEDURES: This is a single-center, retrospective case series of all patients with bilateral retinoblastoma presenting from 2010 to 2014.
RESULTS: A total of 44 patients were included in the study. Visual impairment was present in 14 (38%) children, legal blindness was present in 7 (19%) children. Bilateral macular tumors (BMT) were associated with visual impairment (12 of 18 patients with BMT, 2 of 19 patients without BMT, p = 0.0006) and legal blindness (7 of 18 patients with BMT, 0 of 19 patients without BMT, p = 0.003). The International Intraocular Retinoblastoma Classification (IIRC) of the better eye also predicted visual impairment (16% in IIRC Group a, b, c, 75% in IIRC Group D, E, p = 0.004) and blindness (3% eye in IIRC Group a, b, c, 50% in Group D, E, p = 0.005). Various non-Snellen visual acuity measures were able to predict visual impairment in pre-verbal children, providing them with early assistance.
CONCLUSIONS: The rates of visual impairment and blindness reported in this paper can be used to counsel families regarding the risk of binocular visual impairment. Early detection and support for visually impaired infants are essential as development can be affected by severe visual impairment.

Entities:  

Keywords:  Blindness; Retinoblastoma; Visual impairment

Year:  2018        PMID: 30675470      PMCID: PMC6341332          DOI: 10.1159/000489313

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  15 in total

1.  Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma.

Authors:  Subina Narang; Arman Mashayekhi; Danielle Rudich; Carol L Shields
Journal:  Clin Exp Ophthalmol       Date:  2012-03-21       Impact factor: 4.207

2.  Attentional processes in young children with congenital visual impairment.

Authors:  Valerie Tadić; Linda Pring; Naomi Dale
Journal:  Br J Dev Psychol       Date:  2009-06

Review 3.  Intraocular retinoblastoma: the case for a new group classification.

Authors:  A Linn Murphree
Journal:  Ophthalmol Clin North Am       Date:  2005-03

4.  Visual outcomes in children with bilateral retinoblastoma.

Authors:  L S Hall; E Ceisler; D H Abramson
Journal:  J AAPOS       Date:  1999-06       Impact factor: 1.220

5.  Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.

Authors:  Francis L Munier; Marie-Claire Gaillard; Aubin Balmer; Sameh Soliman; Gregory Podilsky; Alexandre P Moulin; Maja Beck-Popovic
Journal:  Br J Ophthalmol       Date:  2012-06-13       Impact factor: 4.638

6.  Developmental outcome, including setback, in young children with severe visual impairment.

Authors:  Naomi Dale; Patricia Sonksen
Journal:  Dev Med Child Neurol       Date:  2002-09       Impact factor: 5.449

7.  Causes and prevalence of visual impairment among adults in the United States.

Authors:  Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2004-04

8.  A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

Authors:  David H Abramson; Ira J Dunkel; Scott E Brodie; Jonathan W Kim; Y Pierre Gobin
Journal:  Ophthalmology       Date:  2008-03-14       Impact factor: 12.079

9.  The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.

Authors:  Takashi Yamane; Akihiro Kaneko; Makoto Mohri
Journal:  Int J Clin Oncol       Date:  2004-04       Impact factor: 3.402

10.  Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.

Authors:  Maria Tsimpida; Dorothy A Thompson; Alki Liasis; Vicki Smith; Judith E Kingston; Mandeep S Sagoo; M Ashwin Reddy
Journal:  Br J Ophthalmol       Date:  2013-09-13       Impact factor: 4.638

View more
  2 in total

Review 1.  Retinoblastoma and vision.

Authors:  Omar Warda; Zishan Naeem; Kelsey A Roelofs; Mandeep S Sagoo; M Ashwin Reddy
Journal:  Eye (Lond)       Date:  2022-01-05       Impact factor: 3.775

Review 2.  Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class-A Meta-Analysis.

Authors:  Anthony B Daniels; Shriji N Patel; Ronald W Milam; Sahar Kohanim; Debra L Friedman; Tatsuki Koyama
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.